| scholarly article | Q13442814 |
| P50 | author | Gadi Pelled | Q73800424 |
| P2093 | author name string | Dan Gazit | |
| Ilan Kallai | |||
| Wafa Tawackoli | |||
| Zulma Gazit | |||
| Edward M Schwarz | |||
| Dmitriy Sheyn | |||
| Doron Cohn Yakubovich | |||
| Susan Su | |||
| Xiaoyu Da | |||
| Galen Cook-Weins | |||
| P2860 | cites work | CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis | Q21134800 |
| Toluidine blue: A review of its chemistry and clinical utility | Q24614087 | ||
| Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling | Q30514534 | ||
| The biology of bone grafts | Q33562930 | ||
| Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. | Q33835146 | ||
| The effect of bisphosphonate and intermittent human parathyroid hormone 1-34 treatments on cortical bone allografts in rabbits. | Q33912453 | ||
| CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model | Q34090214 | ||
| CCN1 and CCN2: blood brothers in angiogenic action. | Q34352095 | ||
| Cardiac mast cells: the centrepiece in adverse myocardial remodelling | Q34410300 | ||
| Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model | Q34544242 | ||
| Morbidity at bone graft donor sites | Q34549541 | ||
| Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair | Q34792085 | ||
| The biology of fracture healing | Q35017085 | ||
| Circadian rhythm of osteocalcin in the maxillomandibular complex. | Q35129090 | ||
| Regulation of skeletogenic differentiation in cranial dermal bone. | Q51979503 | ||
| Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. | Q53255580 | ||
| Donor site pain from the ilium. A complication of lumbar spine fusion. | Q54347528 | ||
| Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34) | Q60607904 | ||
| Cranioplasty With Adipose-Derived Stem Cells and Biomaterial: A Novel Method for Cranial Reconstruction | Q61163072 | ||
| Mast cells in fibrotic lung disorders | Q72300723 | ||
| Transplantation immunity in bone homografting | Q78516292 | ||
| Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material | Q80230562 | ||
| The role of mast cells in the early stages of wound healing | Q82441290 | ||
| Bone autografting of the calvaria and craniofacial skeleton: historical background, surgical results in a series of 15 patients, and review of the literature | Q35178794 | ||
| Mast cells in allergy and beyond | Q35214655 | ||
| The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials | Q35223685 | ||
| Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. | Q35563900 | ||
| Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction | Q35659476 | ||
| Mast cells contribute to scar formation during fetal wound healing | Q35672929 | ||
| Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. | Q36071882 | ||
| Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling | Q36177028 | ||
| PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis | Q36517935 | ||
| The use of parathyroid hormone in the treatment of osteoporosis | Q36624534 | ||
| Adeno-associated virus-coated allografts: a novel approach for cranioplasty | Q36838524 | ||
| The combined effect of parathyroid hormone and bone graft on implant fixation | Q36926814 | ||
| Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? | Q37143902 | ||
| Complications of cranioplasty following decompressive craniectomy: analysis of 62 cases | Q37503193 | ||
| Complications related to osteobiologics use in spine surgery: a systematic review | Q37734808 | ||
| Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect | Q37762133 | ||
| The use of bone grafts and alloplastic materials in cranioplasty | Q37770079 | ||
| Calcium Phosphate Cements in Skull Reconstruction: A Meta-Analysis | Q37795506 | ||
| Cranial bone defects: current and future strategies | Q37814375 | ||
| Complications of hydroxyapatite bone cement in secondary pediatric craniofacial reconstruction. | Q37828356 | ||
| The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma. | Q37853582 | ||
| Induction and patterning of intramembranous bone | Q37881640 | ||
| Titanium cranioplasty and the prediction of complications | Q38019002 | ||
| Cranial bone grafts for post-traumatic facial defects | Q39675275 | ||
| Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. | Q40565579 | ||
| Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation | Q40881030 | ||
| Freeze-dried allogeneic segmental cortical-bone grafts in dogs | Q40967248 | ||
| Role of mast cells in wound healing process after glass-fiber composite implant in rats | Q41886421 | ||
| Mast cells: the forgotten cells of renal fibrosis | Q43081573 | ||
| Imaging transgene expression in live animals | Q45198958 | ||
| Microcomputed tomography-based structural analysis of various bone tissue regeneration models. | Q45248719 | ||
| Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development | Q45859087 | ||
| Ultrasound-based nonviral gene delivery induces bone formation in vivo | Q45873072 | ||
| Bioluminescent imaging in bone. | Q45877350 | ||
| Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure | Q46250682 | ||
| Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells | Q46275778 | ||
| Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium | Q46280537 | ||
| Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis. | Q46446530 | ||
| Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model | Q47440545 | ||
| Repairing holes in the head: a history of cranioplasty | Q47800171 | ||
| Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells. | Q50870395 | ||
| Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. | Q51753060 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4462-4471 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | PTH promotes allograft integration in a calvarial bone defect | |
| P478 | volume | 10 |
| Q92087390 | Bone stock reconstruction for huge bone loss using allograft-bones, bone marrow, and teriparatide in an infected total knee arthroplasty |
| Q91972701 | Bone-chip system to monitor osteogenic differentiation using optical imaging |
| Q30713694 | Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts. |
| Q36852779 | Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts |
| Q35972558 | Engraftment and bone mass are enhanced by PTHrP 1-34 in ectopically transplanted vertebrae (vossicle model) and can be non-invasively monitored with bioluminescence and fluorescence imaging. |
| Q42650829 | High dose teriparatide (rPTH1-34) therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model. |
| Q59811783 | Molecular pain markers correlate with pH-sensitive MRI signal in a pig model of disc degeneration |
| Q37384580 | Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice |
| Q36756870 | PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries |
| Q51800119 | PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology. |
| Q37661167 | Parathyroid Hormone (1-34) Might Not Improve Early Bone Healing after Sinus Augmentation in Healthy Rabbits. |
| Q89101016 | Phenotyping the Microvasculature in Critical-Sized Calvarial Defects via Multimodal Optical Imaging |
| Q38611744 | Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration |
| Q36384656 | Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model |
Search more.